The National Medical Products Administration (NMPA) has released the 65th batch of reference drugs for the Generic Quality Consistency Evaluation (GQCE) work. This update includes 67 new specifications, encompassing 8 injectables and 21 specifications with modifications.
Details of the Update
The modifications in this batch involve changes and increases in marketing authorization holders (MAHs). This comprehensive update aims to enhance the quality and consistency of generic drugs, ensuring they meet the same high standards as their branded counterparts.
Significance of the GQCE
The GQCE is a critical initiative to improve the quality of generic drugs in the market. By regularly updating the reference drug list, the NMPA continues to support the development of high-quality, cost-effective generic medications, benefiting both healthcare providers and patients.-Fineline Info & Tech
